Vaso SG&A Expenses 2010-2024 | VASO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$228.6B
Intuitive Surgical (ISRG)	$203.7B
Alcon (ALC)	$44.9B
Edwards Lifesciences (EW)	$42.7B
IQVIA Holdings (IQV)	$36.5B
IDEXX Laboratories (IDXX)	$34.6B
DexCom (DXCM)	$33.9B
Mettler-Toledo (MTD)	$28.8B
Waters (WAT)	$24.7B
STERIS (STE)	$21.8B
SONOVA HOLDING (SONVY)	$20.8B
Hologic (HOLX)	$16.3B
Fresenius Medical Care AG KGaA (FMS)	$14.6B
Globus Medical (GMED)	$12.6B
Sysmex ADR (SSMXY)	$12B
Penumbra (PEN)	$10.2B
Masimo (MASI)	$9.3B
Glaukos (GKOS)	$8.6B
Teleflex (TFX)	$8.4B
Integer Holdings (ITGR)	$4.8B
Inari Medical (NARI)	$4.7B
PROCEPT BioRobotics (PRCT)	$3.8B
Veracyte (VCYT)	$3.5B
LivaNova (LIVN)	$2.7B
Nihon Kohden (NHNKY)	$2.6B
Tandem Diabetes Care (TNDM)	$2.4B
TransMedics (TMDX)	$2.3B
Elekta AB (EKTAY)	$2.3B
Integra LifeSciences Holdings (IART)	$2B
Alphatec Holdings (ATEC)	$1.7B